Finance

Lists
SI:NYSE
Shoulder Innovations Inc
USD 19,01
+1,39%
(+0,26) 1D
USD 19,01
0,00% (0,00)
After hours
Closed: 2 Okt., 16:00:06 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SI...
Open
USD 18,89
High
USD 19,49
Low
USD 18,54
Mkt. cap
395,77 m
Avg. vol.
120,18 k
Volume
144,35 k
52-wk high
USD 24,60
52-wk low
USD 10,92
EPS
-USD 0,56
Shares outstanding
20,82 m
No. of employees
74
Open
USD 18,89
High
USD 19,49
Low
USD 18,54
Mkt. cap
395,77 m
Avg. vol.
120,18 k
Volume
144,35 k
52-wk high
USD 24,60
52-wk low
USD 10,92
EPS
-USD 0,56
Shares outstanding
20,82 m
No. of employees
74
News stories
From web sources and news partners
About Shoulder Innovations Inc
CEO-
Employees74
Founded2009
Headquarters-
SectorMedical device
Websiteshoulderinnovations.com
Analyst ratings
Based on 3 analysts giving stock ratings to SI in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for SI in the last 3 months.
Highest
Current USD 19,01
USD 28,00 (+47,29%)
Average
USD 26,33 (+38,51%)
Lowest
USD 25,00 (+31,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew O'Brien
Piper Sandler
Buy
Maintained
USD 25,00
+31,5%
09/28/2026
Patrick Wood
UBS
Buy
Reiterated
USD 28,00
+47,3%
08/10/2026
Ryan Zimmerman
BTIG
Buy
Reiterated
USD 26,00
+36,8%
08/07/2026
Unknown Analyst
UBS
Buy
Initiated
USD 27,00
+42%
07/28/2026
David Roman
Goldman Sachs
Buy
Maintained
USD 20,00
+5,2%
05/13/2026
Last report
06 Aug. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-USD 0,46 / -USD 0,41
-13,53%miss
Revenue / Est. (USD)
17,18 m / 16,53 m
+3,91%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
11,76 m
14,42 m
16,71 m
17,18 m
Cost of goods sold
2,80 m
3,36 m
3,72 m
3,73 m
Cost of revenue
2,80 m
3,36 m
3,72 m
3,73 m
Research and development expenses
1,52 m
3,22 m
3,75 m
3,39 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15,08 m
16,34 m
18,21 m
20,09 m
Operating expense
16,60 m
19,56 m
21,96 m
23,48 m
Total operating expenses
19,40 m
22,92 m
25,68 m
27,21 m
Operating income
-7,64 m
-8,50 m
-8,98 m
-10,04 m
Other non operating income
1,21 m
-267,00 k
161,00 k
-201,00 k
EBT including unusual items
-8,73 m
-7,77 m
-8,38 m
-10,15 m
EBT excluding unusual items
-6,51 m
-8,18 m
-8,38 m
-9,56 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,73 m
-7,77 m
-8,38 m
-10,15 m
Net profit margin
-74,25%
-53,91%
-50,15%
-59,11%
Earnings per share
-0,64
-0,38
-0,41
-0,46
Interest and investment income
-
591,00 k
436,00 k
673,00 k
Interest expense
-78,00 k
-
-
-
Net interest expenses
-78,00 k
591,00 k
436,00 k
673,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-6,87 m
-7,60 m
-7,92 m
-8,93 m
Gain or loss from assets sale
-
100,00 k
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme